Bone News and Research

RSS

Researchers identify microRNA-155 as prognostic marker, treatment target in patients with AML

A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal acute myeloid leukemia, or CN-AML).

14 May 2013

Researchers identify link between GPR126 gene and adolescent idiopathic scoliosis

Researchers from the RIKEN Center for Integrative Medical Sciences in Japan have identified the first gene to be associated with adolescent idiopathic scoliosis (also called AIS) across Asian and Caucasian populations.

13 May 2013

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema.

13 May 2013

FORTIFY I: An expandable corpectomy spacer from Globus Medical

Globus Medical, Inc. (NYSE: GMED), a leading spinal implant manufacturer, today announced the launch of FORTIFY I, an expandable corpectomy spacer with integrated screws for further stability in addition to supplemental fixation.

10 May 2013

SLU SNMA students receive Leadership in Institutional Diversity Award

A group of 40 students are part of Saint Louis University's Student National Medical Association chapter (SNMA), who are striving to reduce health disparities locally. This year, they received the Leadership in Institutional Diversity Award, a recognition given to a university for serving as an outstanding example of leadership and innovation in promoting and maintaining institutional diversity.

10 May 2013

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Novartis announced that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.

10 May 2013

New data help explain hospital pricing, but experts caution that Medicare and insurers get much lower rates

Although the government releases a list of what hospitals across the country charge for common procedures in an effort to make health costs more transparent, few patients or their insurers pay that.

10 May 2013

Small diameter dual-thread suture anchor and new PTRC repair system launched by Mitek Sports Medicine

Mitek Sports Medicine, a leading orthopaedics sports medicine company, announced the launch of the HEALIX™ 3.4mm Suture Anchor, the company's smallest dual-thread suture anchor for rotator cuff repair, and the launch of a new double-loaded minimally invasive partial thickness rotator cuff (PTRC) repair system, as part of its HEALIX TRANSTENDTM Implant System.

9 May 2013

Scientists identify new class of immune cells that suppress genital herpes

Fred Hutchinson Cancer Research Center and University of Washington scientists have identified a class of immune cells that reside long-term in the genital skin and mucosa and are believed to be responsible for suppressing recurring outbreaks of genital herpes.

9 May 2013

First Edition: May 9, 2013

Today's headlines include reports about the politics surrounding the health law, both in terms of the latest GOP push for repeal and the Obama administration's implementation efforts.

9 May 2013

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Loyola University Medical Center has opened a new 20-bed unit for patients undergoing stem cell transplants for cancers such as leukemia, lymphoma and multiple myeloma.

9 May 2013

New therapeutic targets for reducing heart disease in people with type 1 diabetes

Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque.

8 May 2013

Cell Medica treats first pediatric patient in ASPIRE Trial

Cell Medica today announced the treatment of the first patient in the ASPIRE Trial, an early stage Phase I/II clinical study investigating the safety and efficacy of Cytovir ADV for the treatment of adenovirus infections in immunosuppressed pediatric patients following bone marrow transplantation.

8 May 2013

New version of FRAX now available for 53 countries

An increasing number of physicians around the world are using FRAX-, a scientifically validated online fracture-risk calculator that has been developed by the World Health Organization Collaborating Centre for Metabolic Bone Diseases at the University of Sheffield, UK.

8 May 2013

Clinical data of cabozantinib to be presented at ASCO meeting

Exelixis, Inc. announced today that cabozantinib will be the subject of nine separate data presentations at the upcoming 2013 Annual Meeting of the American Society of Clinical Oncology.

8 May 2013

Janssen enrolls patients in expanded access program for mantle cell lymphoma

Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.

7 May 2013

800 IU of vitamin D3 per day is recommended for preterm infants, says study

Preterm infants may need to be given 800 international units (IU) of vitamin D a day to ensure they develop strong bones, according to a study to be presented Sunday, May 5, at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.

6 May 2013

Program on Medicine and Religion selects faculty scholars

The University of Chicago Medicine's Program on Medicine and Religion has selected its second round of faculty scholars whose focus will be on the relationship between a physician's spirituality and their ability to deal with the pressures of practicing medicine.

6 May 2013

Rare mutation confers high risk of osteoporosis and certain cancers

deCODE genetics (an Amgen subsidiary) and Illumina, global leaders in analyzing and understanding the human genome, together with scientists from the National Hospital of Iceland and the University of Iceland reported today in the journal Nature the identification of a rare nonsense mutation that confers high risk of osteoporosis and osteoporosis related traits.

6 May 2013

Single antibody could be key to treating multiple myeloma

A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment.

6 May 2013

Bone News and Research

Researchers identify microRNA-155 as prognostic marker, treatment target in patients with AML

Researchers identify link between GPR126 gene and adolescent idiopathic scoliosis

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

FORTIFY I: An expandable corpectomy spacer from Globus Medical

SLU SNMA students receive Leadership in Institutional Diversity Award

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

New data help explain hospital pricing, but experts caution that Medicare and insurers get much lower rates

Small diameter dual-thread suture anchor and new PTRC repair system launched by Mitek Sports Medicine

Scientists identify new class of immune cells that suppress genital herpes

First Edition: May 9, 2013

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

New therapeutic targets for reducing heart disease in people with type 1 diabetes

Cell Medica treats first pediatric patient in ASPIRE Trial

New version of FRAX now available for 53 countries

Clinical data of cabozantinib to be presented at ASCO meeting

Janssen enrolls patients in expanded access program for mantle cell lymphoma

800 IU of vitamin D3 per day is recommended for preterm infants, says study

Program on Medicine and Religion selects faculty scholars

Rare mutation confers high risk of osteoporosis and certain cancers

Single antibody could be key to treating multiple myeloma

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News